News & Updates
Filter by Specialty:
Metformin plus liraglutide eases glycemia but not gluconeogenesis in youth-onset T2D
Use of metformin with or without liraglutide results in improved glycaemia but falls short of suppressing the high rates of gluconeogenesis in patients with youth-onset type 2 diabetes (Y-T2D), reports a study.
Metformin plus liraglutide eases glycemia but not gluconeogenesis in youth-onset T2D
28 May 2024
Dupilumab lessens symptoms, betters life quality in atopic hand and foot dermatitis
Treatment with dupilumab substantially improves symptoms, quality of life, and other outcomes in patients with atopic hand and foot dermatitis (H/F AD), with an acceptable safety profile, results of a study have shown.
Dupilumab lessens symptoms, betters life quality in atopic hand and foot dermatitis
28 May 2024
Earlier menopause, higher CV risk may lead to cognitive decline
Earlier menopause (occurring before age 49) coupled with higher risk of cardiovascular disease (CVD) is associated with an increased risk of cognitive problems later in life, a study suggests.
Earlier menopause, higher CV risk may lead to cognitive decline
28 May 2024
MAURIS interim safety and efficacy results in “real-world” ES-SCLC patients similar to IMpower133
Interim results of the Italian, multicentre, open-label, phase IIIb MAURIS trial in “real-world” patients with untreated extensive-stage small-cell lung cancer (ES-SCLC) show similar safety and efficacy to those achieved by atezolizumab plus carboplatin and etoposide in the pivotal, phase I/III IMpower133 trial.
